Back
Blueprint Medicines Vs. Target Industry Stock Comparison
Sell
37
BPMC
Blueprint Medicines
Last Price:
94.25
Seasonality Move:
5.92%
Sell
22
TGT
Target
Last Price:
125.00
Seasonality Move:
4.08%
Sell
37
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
- The current Blueprint Medicines [BPMC] share price is $94.15. The Score for BPMC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Target (TGT)
is a Sell
Is Target a Buy, Sell or Hold?
- The current Target [TGT] share price is $125.01. The Score for TGT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- TGT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $94.15
The current trend is moderately bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.
BPMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.37 | Buy |
| Relative Strength Index (14 RSI): | 52.43 | Buy |
| Chaikin Money Flow: | -650985 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (85.74 - 97.86) | Buy |
| Bollinger Bands (100): | (85.66 - 106.02) | Sell |
TGT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.11 | Sell |
| Relative Strength Index (14 RSI): | 28.67 | Sell |
| Chaikin Money Flow: | 9125665 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (138.23 - 157.41) | Sell |
| Bollinger Bands (100): | (141.76 - 157.14) | Sell |
BPMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.95 | Buy |
| 20-day SMA: | 93.65 | Buy |
| 50-day SMA: | 90.42 | Buy |
| 200-day SMA: | 96.05 | Sell |
| 8-day EMA: | 94.56 | Sell |
| 20-day EMA: | 93.49 | Buy |
| 50-day EMA: | 92.48 | Buy |
| 200-day EMA: | 91.19 | Buy |
TGT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 142.68 | Sell |
| 20-day SMA: | 147.3 | Sell |
| 50-day SMA: | 151.17 | Sell |
| 200-day SMA: | 153.74 | Sell |
| 8-day EMA: | 137.63 | Sell |
| 20-day EMA: | 145.05 | Sell |
| 50-day EMA: | 148.83 | Sell |
| 200-day EMA: | 149.38 | Sell |
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.64 per share.
Target Earnings Growth & TGT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.33 per share, an increase this year of $2.81 per share, and an increase next year of $0.33 per share.
Blueprint Medicines Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Target Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||